5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.35%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
16.80%
Gross profit growth at 50-75% of HUH1V.HE's 30.38%. Martin Whitman would question if cost structure or brand is lagging.
19.63%
EBIT growth below 50% of HUH1V.HE's 563.37%. Michael Burry would suspect deeper competitive or cost structure issues.
19.63%
Operating income growth under 50% of HUH1V.HE's 563.37%. Michael Burry would be concerned about deeper cost or sales issues.
18.73%
Net income growth under 50% of HUH1V.HE's 148.09%. Michael Burry would suspect the firm is falling well behind a key competitor.
21.43%
EPS growth under 50% of HUH1V.HE's 144.44%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
21.43%
Diluted EPS growth under 50% of HUH1V.HE's 144.44%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.23%
Share reduction while HUH1V.HE is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.23%
Reduced diluted shares while HUH1V.HE is at 0.08%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
19.74%
Positive OCF growth while HUH1V.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
970.59%
Positive FCF growth while HUH1V.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-26.09%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 52.40%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.14%
5Y revenue/share CAGR under 50% of HUH1V.HE's 41.00%. Michael Burry would suspect a significant competitive gap or product weakness.
8.90%
3Y revenue/share CAGR under 50% of HUH1V.HE's 18.60%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
591.58%
Positive long-term OCF/share growth while HUH1V.HE is negative. John Neff would see a structural advantage in sustained cash generation.
299.37%
5Y OCF/share CAGR above 1.5x HUH1V.HE's 83.23%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
258.96%
Positive 3Y OCF/share CAGR while HUH1V.HE is negative. John Neff might see a big short-term edge in operational efficiency.
148.99%
Net income/share CAGR 1.25-1.5x HUH1V.HE's 108.09%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
150.10%
5Y net income/share CAGR above 1.5x HUH1V.HE's 62.41%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
142.86%
3Y net income/share CAGR above 1.5x HUH1V.HE's 8.75%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
53.48%
5Y equity/share CAGR is in line with HUH1V.HE's 58.53%. Walter Schloss would see parallel mid-term profitability and retention policies.
25.43%
3Y equity/share CAGR similar to HUH1V.HE's 26.00%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.29%
AR growth well above HUH1V.HE's 7.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.73%
Inventory growth well above HUH1V.HE's 10.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.40%
Negative asset growth while HUH1V.HE invests at 9.26%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.83%
We have a declining book value while HUH1V.HE shows 5.49%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-11.02%
We’re deleveraging while HUH1V.HE stands at 19.23%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 14.89%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-2.89%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.